The U.S. Department of Agriculture is mobilizing resources to contain the New World screwworm following the confirmed detection of the parasite in Texas. As of June 2026, the USDA has …
Biotech and Pharmaceuticals
-
-
Strengthening Public Health: Surveillance and Response to Contagious Diseases in U.S. Cities As the threat of highly contagious diseases like measles and respiratory viruses continues to evolve, U.S. Cities are …
-
Innovent Biologics and Pfizer Announce $10.5 Billion Oncology Partnership Shares of Hong Kong-listed Innovent Biologics surged on Friday following the announcement of a massive global licensing and collaboration agreement with …
-
TrumpRx Expands: Platform Adds Generic Drugs and New Pharmacy Tools The Trump administration is scaling its direct-to-consumer drug pricing platform, TrumpRx.gov, with a significant expansion of its offerings. On Monday, …
-
UnitedHealth Group Beats Q1 2026 Estimates, Raises Profit Outlook UnitedHealth Group reported first-quarter earnings that exceeded Wall Street expectations for both revenue and earnings per share on Tuesday, April 21, …
-
Merck to Acquire Terns Pharma for $6 Billion to Bolster Cancer Pipeline Pharmaceutical giant Merck & Co. announced Wednesday it is nearing a $6 billion all-cash acquisition of U.S. Biotech …
-
The Rising Cost of Menstrual Products and Consumer Response Inflation and evolving tariff policies are impacting household budgets, and one often-overlooked area of increased expense is menstrual products. Despite declining …
-
Lilly’s Retatrutide Shows Promise in Type 2 Diabetes Trial, Delivering Significant Weight Loss Eli Lilly and Company announced positive topline results from the TRANSCEND-T2D-1 Phase 3 clinical trial evaluating retatrutide, …
-
Eli Lilly Launches Zepbound KwikPen for More Convenient Weight Management Eli Lilly and Company announced on Monday the availability of a new delivery option for its blockbuster obesity drug, Zepbound …
-
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in …